Amalgamated Bank Sesen Bio, Inc. Transaction History

Amalgamated Bank

  • $12.1 Billion
  • Q3 2024

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Aug 15, 2022
SELL
$0.38 - $0.89 $12,454 - $29,168
-32,774 Closed
0 $0
Q1 2022

Jun 30, 2022
SELL
$0.58 - $0.86 $1,409 - $2,090
-2,431 Reduced 6.91%
32,774 $20,000
Q4 2021

Feb 15, 2022
BUY
$0.73 - $1.28 $1,874 - $3,287
2,568 Added 7.87%
35,205 $29,000
Q3 2021

Oct 29, 2021
BUY
$0.77 - $4.91 $272 - $1,738
354 Added 1.1%
32,637 $26,000
Q2 2021

Aug 16, 2021
BUY
$2.18 - $4.66 $70,376 - $150,438
32,283 New
32,283 $149,000

Others Institutions Holding SESN

# of Institutions
1
Shares Held
0
Call Options Held
0
Put Options Held
0
View Full List

About Sesen Bio, Inc.

SESN Quotes by TradingView
  • Ticker SESN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 201,702,000
  • Market Cap $127M
  • Description
  • Sesen Bio, Inc., a late-stage clinical company, focuses on designing, engineering, developing, and commercializing targeted fusion protein therapeutics (TFPTs) for the treatment patients with cancer. Its lead product candidates include Vicineum, a locally-administered targeted fusion protein that is in Phase III clinical trials for the treatment...
More about SESN
Track This Portfolio

Track Amalgamated Bank Portfolio

Follow Amalgamated Bank and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Amalgamated Bank, based on Form 13F filings with the SEC.

News

Stay updated on Amalgamated Bank with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email